drugset / Trial / NCT00890175
Staccato Loxapine Pulmonary Safety in Patients With Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety of 2 inhaled doses of Staccato Loxapine within a day in patients with asthma.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | loxapine | Small molecule | 10 mg | Inhaled |